Form 8-K - Current report:
SEC Accession No. 0001279569-22-001053
Filing Date
2022-06-27
Accepted
2022-06-27 16:12:59
Documents
13
Period of Report
2022-06-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm   iXBRL 8-K 27363
2 NEWS RELEASE DATED JUNE 27, 2022 ex991.htm EX-99.1 26776
  Complete submission text file 0001279569-22-001053.txt   236463

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA epix-20220627.xsd EX-101.SCH 2965
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE epix-20220627_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epix-20220627_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3690
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37410 | Film No.: 221044693
SIC: 2834 Pharmaceutical Preparations